IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $83,000 | -63.3% | 8,616 | +77.0% | 0.01% | 0.0% |
Q4 2020 | $226,000 | +41.2% | 4,869 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $160,000 | -70.3% | 4,869 | -75.2% | 0.00% | -66.7% |
Q2 2020 | $539,000 | -10.5% | 19,627 | -2.5% | 0.01% | -14.3% |
Q1 2020 | $602,000 | -14.6% | 20,121 | -21.0% | 0.01% | -12.5% |
Q4 2019 | $705,000 | +95.8% | 25,473 | -32.7% | 0.02% | +100.0% |
Q1 2019 | $360,000 | +7.5% | 37,870 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $335,000 | +6.7% | 37,870 | +35.6% | 0.01% | +14.3% |
Q3 2018 | $314,000 | – | 27,937 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |